Table 1: Proportion of BL anti-CCP2 lgM-postive patients who achieved Boolean remission, by serostatus at Mth 12
Table 1: Proportion of BL anti-CCP2 lgM-postive patients who achieved Boolean remission, by serostatus at Mth 12